Agency News from Centron, Jocoto and Harrison and Star

Share this article:
Centron won the agency of record assignment for Cephalon's AMRIX capsules as well as the medical education agency assignment for a new product being developed by Acorda Therapeutics.

Jocoto said it has won launch assignments from Abaxis' animal health unit, IntraPace, Luminous Medical, Relievant Medical and a minimally invasive back surgery company. The San Francisco-based medical agency said it has seen a 25%-30% increase in spend since the economic downturn began in 2009.

Harrison and Star was named agency of record for the launch of Incyte's Janus-Associated Kinase inhibitor currently known as INCB18424, a first-in-class compound that, if approved, could become the first drug indicated for myleofibrosis.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Agency

ExL Pharma (Digital Pharma East 2013)

ExL Pharma (Digital Pharma East 2013)

Jayson Mercado, head of digital events at ExL Pharma, chats to MM&M Executive Editor, Marc Iskowitz, about the changing industry landscape and the evolution of digital. [SPONSORED CONTENT]

e-Healthcare Solutions (Digital Pharma East 2013)

e-Healthcare Solutions (Digital Pharma East 2013)

R.J. Lewis, President and CEO of e-Healthcare Solutions, shares his unique views on informed targeting with Marc Iskowitz, MM&M Executive Editor. [SPONSORED CONTENT]

IOMEDIA (Digital Pharma East 2013)

IOMEDIA (Digital Pharma East 2013)

MM&M Executive Editor, Marc Iskowitz, discusses pharma's digital maturation process with Peter Korian, President and Founder of IOMEDIA. [SPONSORED CONTENT]